Boris A. Hadaschik

Apr 9, 2024 | europeanurology.com | Francisco E. Vera-Badillo |Markus Eckstein |Boris A. Hadaschik

Powles T, Valderrama BP, Gupta S, et al. N Engl J Med 2024;390:875–88In EV-302, patients with biomarker-unselected untreated locally advanced or metastatic urothelial carcinoma (mUC) were randomly assigned to receive either enfortumab vedotin + pembrolizumab (EV/P; 442 patients) or platinum-based chemotherapy (444 patients) [[1]Powles T. Valderrama B.P. Gupta S. et al. Enfortumab vedotin and pembrolizumab in untreated advanced urothelial cancer. ].

Mar 1, 2024 | jnm.snmjournals.org | Tobias Maurer |Christian Thomas |Boris A. Hadaschik |Molecular Imaging

The DETECT trial presented by Schilham et al. in The Journal of Nuclear Medicine constitutes one of the first prospective trials on prostate-specific membrane antigen (PSMA) radioguided surgery (RGS) in primary prostate cancer patients (1).

Feb 29, 2024 | urotoday.com | Boris A. Hadaschik

Read the Full Video TranscriptAlicia Morgans: Hi, I am so excited to be here at ASCO GU 2024 where I have the privilege of speaking with Dr. Boris Hadaschik from Essen, Germany. Thank you so much for being here with me today. Boris Hadaschik: Oh, thank you for the invitation, Alicia. Alicia Morgans: Well, wonderful.

Feb 15, 2024 | jnm.snmjournals.org | Tobias Maurer |Christian Thomas |Boris A. Hadaschik |Molecular Imaging

The DETECT trial presented by Schilham et al. in The Journal of Nuclear Medicine constitutes one of the first prospective trials on prostate-specific membrane antigen (PSMA) radioguided surgery (RGS) in primary prostate cancer patients (1).

Jul 3, 2023 | urotoday.com | Boris A. Hadaschik

Read the Full Video TranscriptAlicia Morgans: Hi. I'm so excited to be here with Professor Boris Hadaschik, who is joining me today from Essen, Germany, where he is the head of urology there. Thank you so much for being here with me today. Boris Hadaschik: Thank you very much for the kind introduction. It's a pleasure being here. Alicia Morgans: Wonderful.